Cadensee

JULY 26, 2021

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. So, this was a prospective, randomized, double blind, placebo-controlled study. Are you seeing some unique trends in China that you think we should kind of pay attention to in the healthcare space that might be coming to the Western world?

Retail 52

Retail Marketing Doctors Food 52

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.

Medical 98

Medical Manufacturing Insurance Side effects 98